Tabriz University of Medical Sciences About    Newsletter    Contact Us    Create Account    Log in  
Advanced Pharmaceutical Bulletin
ISSN: 2228-5881      eISSN: 2251-7308  
Export citation
Reference Manager

Cite by
Google Scholar

Article History
Submitted: 06 Apr 2014
Revised: 18 Jun 2014
First published online: 01 Jun 2015

Article Access Statistics
Abstract Page Views: 415
PDF Downloads: 149
Full Text Views: 0

Adv Pharm Bull. 2015;5(2):201-208 doi: 10.15171/apb.2015.028
PMID:26236658        PMCID:PMC4517083

Adenovirus-Mediated Over-Expression of Nrf2 Within Mesenchymal Stem Cells (MSCs) Protected Rats Against Acute Kidney Injury

Original Research

Mohammad Mohammadzadeh-Vardin, Mehryar Habibi Roudkenar * , Ali Jahanian-Najafabadi

1 Department of Anatomical Sciences and Pathology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
2 Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.
3 Department of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences and Health Services, Isfahan, Iran.

Purpose: Recent developments in the field of cell therapy have led to a renewed interest in treatment of acute kidney injury (AKI). However, the early death of transplanted mesenchymal stem cells (MSCs) in stressful microenvironment of a recipient tissue is a major problem with this kind of treatment. The objective of this study was to determine whether overexpression of a cytoprotective factor, nuclear factor erythroid-2 related factor 2 (Nrf2), in MSCs could protect rats against AKI. Methods: The Nrf2 was overexpressed in MSCs by recombinant adenoviruses, and the MSCs were implanted to rats suffering from cisplatin-induced AKI. Results: The obtained results showed that transplantation with the engineered MSCs ameliorates cisplatin-induced AKI. Morphologic features of the investigated kidneys showed that transplantation with the MSCs in which Nrf2 had been overexpressed significantly improved the complications of AKI. Conclusion: These findings suggested that the engineered MSCs might be a good candidate to be further evaluated in clinical trials. However, detailed studies must be performed to investigate the possible carcinogenic effect of Nrf2 overexpression.

First name  
Last name  
Email address  
Security code

This Article

Google Scholar
Articles by Mohammadzadeh-Vardin M
Articles by Habibi Roudkenar M
Articles by Jahanian-Najafabadi A

Articles by Mohammadzadeh-Vardin M
Articles by Habibi Roudkenar M
Articles by Jahanian-Najafabadi A

Similar articles in PubMed

Share this article!

Press Manuscript Online. Powered by MAADRAYAN